Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1
Zhou Tong(Beijing Normal University), George F. Gao(Chinese Academy of Sciences), Guizhen Wu(Chinese Center For Disease Control and Prevention), Lan Deng(Tianjin Agricultural University), Yingzi Cui(Changchun University of Chinese Medicine), Qihui Wang(Shanxi Agricultural University), Haiyun Ma(Sichuan University), Guowen Jia(Sichuan University), Zhimin Cheng(Shanxi Academy of Building Research), Kefang Liu(Wenzhou Medical University), Jing Lou(Buchang Pharma (China)), Jianyu Tong(Shanxi Academy of Building Research), Yufeng Xie(Chinese Academy of Sciences), Jianxun Qi(Chinese Academy of Sciences), Rong Zhang(Huazhong Agricultural University), Shihua Li(Fuzhou University), Xin Zhao(Chinese Academy of Sciences), Rui Song(Capital Medical University), Zezhong Zhang(Chinese Academy of Sciences), Haomin Huang(Fox Chase Cancer Center), Xiao Xing(Shanxi Academy of Building Research), Zhaoming Su(Sichuan University), Wenwen Lei(China Pharmaceutical University)
Cited by 15
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k